Galectin network in osteoarthritis: galectin-4 programs a pathogenic signature of gene and effector expression in...

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Galectins are galactose-binding proteins involved in various biological processes.
• Galectin-4 (Gal-4) has tandem carbohydrate recognition domains and functions in glycoprotein routing.
• The role of Gal-4 in osteoarthritis (OA) pathogenesis is not well understood.

Purpose of the Study:

• To investigate the role of Galectin-4 (Gal-4) in osteoarthritis (OA) pathogenesis.
• To determine the correlation between Gal-4 expression and cartilage degradation in OA.
• To elucidate the molecular mechanisms underlying Gal-4's effect on OA chondrocytes.

Main Methods:

• In vivo analysis of Gal-4 expression in OA cartilage.
• In vitro studies using primary human OA chondrocytes.
• RT-qPCR and transcriptome data processing for mRNA profiling.
• Analysis of NF-κB pathway activation (p65 phosphorylation).
• 3D pellet cultures to assess Gal-4's effect on chondrocytes.

Main Results:

• Galectin-4 (Gal-4) expression is upregulated in osteoarthritis (OA) correlating with cartilage degradation.
• Gal-4 binding induces upregulation of pro-degradative and pro-inflammatory proteins, including IL-1β and MMP-13, in OA chondrocytes.
• Gal-4 activates the NF-κB pathway via p65 phosphorylation.
• Gal-4 promotes chondrocyte degradation in 3D cultures.

Conclusions:

• Galectins, including Gal-4, may act as a network in osteoarthritis pathogenesis.
• Gal-4 plays a significant role in driving OA progression and cartilage degradation.
• Targeting galectin activity presents a potential future therapeutic strategy for OA.